Sickle cell disease (SCD) is a prevalent inherited blood disorder, particularly affecting
populations in Africa. This review examined the disease's burden, its diverse clinical …

Background The protective effect of certain haemoglobinopathies, such as HbS, HbC, and α-
thalassaemia, against severe malaria has long been established; however, there is only …

Introduction The prevalence of stroke in SCD patients was reported to be around 4%;
however, the pediatric category was among the higher risk group for stroke compared to …

Background Diabetes mellitus, human immunodeficiency virus (HIV), hepatitis B and
anaemia are major global public health issues according to the World Health Organization …

Background The uptake of sickle cell trait (SCT) test is challenged by several factors. A
community of healthcare professionals educating the public to undergo screening is critical …

Background The sporadic nature of blood transfusion therapy coupled with the alteration of
HAMP genes may exacerbate the risk of iron burden in sickle cell anaemia (SCA) patients …

Introduction Sickle cell disease (SCD) is a genetic blood disorder caused by a mutation in
the HBB gene, which encodes the beta-globin subunit of hemoglobin. This mutation leads to …

Aim: The present study was conducted to generate data on awareness and incidence of
sickle cell disease (SCD) and also to adduce the widespread myths peddled about SCD …

Background: Sickle cell disease (SCD) is a hereditary illness that is prevalent in malaria-
prone locations. In these endemic locations, it has historically been linked to high rates of …

Background Sickle cell disease (SCD) is a major public health concern in sub-Saharan
Africa, accounting for nearly 75% of the global disease burden. The current analysis …